Lin et al. confirmed that fascaplysin selectively inhibited endothelial cell proliferation toward tumor cells in low concentrations and inhibited the secretion and expression of VEGF in Bel-7402 cells [36]. The gene discussed is VEGFA; the disease is neoplasm.